Patterns of proinflammatory cytokines and inhibitors during typhoid fever by Keuter, M. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
This full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/14901
 
 
 
Please be advised that this information was generated on 2014-11-11 and may be subject to
change.
1306
Patterns of Proinflammatory Cytokines and Inhibitors during Typhoid Fever
Monique Keuter, Edi Dharmana, M. Hussein Gasem,
Johanna van der Ven-Jongekrijg,
Robert Djokomoeljanto, Wil M. V. Dolmans,
Pierre Demacker, Robert Sauerwein, Harald Gallati, 
and Jos W. M. van der Meer
Cytokines and inhibitors in plasma were measured in 44 patients with typhoid fever. Ex vivo 
production o f  the cytokines was analyzed in a whole blood culture system with and without 
lipopolysaccharide (LPS). Acute phase circulating concentrations o f  cytokines (± S D ) were as 
follows: interleukin (IL)-1£, < 1 4 0  pg/mL; tumor necrosis factor-« (TN Fa), 130 ±  50 pg/mL;
IL-6, 96 ±  131 pg/mL; and IL-8, 278 ±  293 pg/m L. Circulating inhibitors were elevated in the 
acute phase: IL-1 receptor antagonist (IL-1RA) w'as 2304 ±  1427 pg/m L  and soluble T N F  
receptors 55 and 75 were 4973 ±  2644 pg/m L  and 22,865 ±  15,143 pg/m L, respectively. LPS- 
stimulated production o f  cytokines was lower during the acute phase than during convalescence 
(mean values: IL-10, 2547 vs. 6576 pg/mL; T N F a, 2609 vs. 6338 pg/mL; IL-6, 2416 vs. 7713  
pg/m L). LPS-stimulated production o f  IL-1 RA was higher in the acute than during the convales­
cent phase (5608 vs. 3977 pg/m L). Inhibited production o f cytokines during the acute phase may 
be due to a switch from a proinflammatory to an antiinflammatory mode.
University Hospital. Nijmegen, Netherlands; Diponegoro University, 
Semarang, Indonesia; F. Hoffman-La Roche, Basel. Switzerland
T yphoid  fever is caused by the facultative intracellular  
gram -negative bacillus Salmonella fyp/ii and occasionally  by 
Salmonella paratyphi. A lthough  sa lm onellae  contain  lipo­
polysaccharide (LPS; bacterial en d otox in ), the clinical pic­
ture o f  typhoid fever differs from gram -negative sepsis, and  
the role o f  en d otox in  in the pathophysiology o f  typhoid fever 
is controversial [1].
T he proinflam m atory cytokines interleukin ( I L ) - l /?, tu­
mor necrosis factor-a (T N F a ; cachectin), IL-6, and IL-8 
have been im plicated in the pathogenesis o f  sepsis caused by 
gram -negative m icroorganism s [2 -4 ] .  W hen  LPS is injected  
intravenously into anim als or hum an volunteers, elevated  
concentrations o f  these cytokines can be detected, and the 
sym ptom s and signs o f  sepsis are m im icked [5 -7 ] .  E levated  
circulating levels o f  T N F a  have been correlated with poor  
prognosis in sepsis, m en in gococcem ia , and cerebral malaria 
[7 -1 0 ] .  In contrast, in in fections with intracellular patho­
gens, such as Leishmania species. Listeria monocytogenes, or 
m ycobacteria, adm inistration o f  T N F a  inhibits the ou t­
growth o f  the m icroorganism s, whereas adm inistration o f  an-
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tibodies to this cytokine are detrim ental [1 1 -1 6 ] . In experi­
m ental Salmonella typhi murium infection in m ice, the role 
o f  TNFa: is similar to that in other intracellular infections  
[1 7 -1 9 ] .  H ow ever, in calves with S. typhimurium  sepsis, the 
cytokine pattern appears to differ from that seen after intrave­
nously  adm inistered LPS. W here T N F a  rose 1 h after LPS 
adm inistration, sa lm onella  sepsis caused a barely detectable  
increase in T N F a  [20].
In contrast to these anim al studies, circulating cytokines  
(T N F a , IL-6, and IL-1/3) were elevated  in children with ty­
phoid fever in C hile [21]. Butler et al. [22] studied the ou t­
com e o f  typhoid fever in adults in N epal and found that 
higher values o f  IL-6 and so luble  T N F  receptor p55 were  
related to poorer outcom e.
In 1989, jo in t research on several aspects o f  typhoid fever 
was started betw een  N ijm egen  U niversity  and D iponegoro  
University. T o  obtain more insight into the pathophysio logy  
o f  typhoid fever, w e m easured levels o f  circulating pyrogenic  
cytokines (IL-1/3, T N F a , TNF/3 [lym photoxin], and IL-6) 
and concentrations o f  IL-8, the cytok ine inhibitor IL-1 re­
ceptor antagonist (IL -1R A ), and the so lub le  T N F  receptors 
p55 and p75 (sT N F -R ). In addition, w e investigated the ca­
pacity o f  b lood cells  to produce IL-1/3, T N F a ,  IL-6, and IL- 
1 R A  ex vivo in the acute and con va lescen t phases o f  hospital­
ized patients with typhoid fever.
W e used the w hole  b lood  cytokine test as described by van 
D euren et al. [23] and Nerad et al. [24]. This assay is sim ple, 
reproducible, and especially  suitable for use in laboratories 
that are not particularly well equipped for work with cy to ­
kines. In addition, the m ethod may be less artificial than is 
isolating m on on u clear  cells over a gradient and probably is a 
m ore natural mirror o f  what happens in vivo, because plasma  
factors and other cells are left in situ.
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Table 1. Characteristics o f 44 hospitalized culture-proven ty­
phoid fever patients.
Characteristic Complicated disease Uncomplicated  disease
No. o f  patients 16 28
Mean age (range), years 2 0 ( 1 4 - 3 4 ) 24 (1 4 -6 0 )
Males/females 7/9 12/16
Median (range) o f  
days with fever
before admission 1 0 .0 ( 4 - 2 0 ) 8.5 (4 -3 0 )
Leukocyte count  at
admission (range) 7.3 X 109/L  (2 .6 -3 7 .0 ) 4.4 X 109/ L ( 1 . 6 -7 .4 )
Complications 16 ---------
Pneumonia 10
Delirium 2
Perforation 5
Bleeding 1
Patients and Methods /v
The study was done in Dr. Kariadi Hospital, Diponegoro U ni­
versity, Semarang, Indonesia, beginning in December 1990. 
Blood and bone marrow cultures were done for all adult patients 
(> 1 4  years old) hospitalized with suspected typhoid fever (de­
fined as fever > 3 8 .5 ° C  and at least one o f  the following signs: 
relative bradycardia, abdominal complaints, mental changes, 
signs o f  complicated typhoid fever, enlarged liver or spleen and 
no apparent other disease). If blood or bone marrow cultures 
were positive for S. typhi or S’, paratyphi A or patients were 
found to have perforated ilea at surgical exploration, typhoid 
fever was considered proven.
A total o f  44 patients were studied. Patient characteristics are 
shown in table 1. Complications o f  typhoid fever were defined 
as gastrointestinal bleeding, intestinal perforation, shock, delir­
ium, stupor or coma, pneumonia, or diffuse intravascular coagu­
lation.
Treatment consisted o f  chloramphenicol (40 mg/kg/day  
orally) if leukocyte counts were > 2  X 109/L. If fever did not 
subside within 6 days, treatment was changed to sulfamethoxa­
zole (800  mg) and trimethoprim (160  mg) twice daily or ampi- 
cillin (1 g four times daily). Surgical patients received ampicil- 
lin, metronidazole, and gentamicin during and after surgery. No  
cyclooxygenase inhibitors were given. Only 2 patients received a 
single dose o f  120 mg o f  dexamethasone, but not before blood 
was obtained for cytokine measurement. Most patients were dis­
charged 7 -1 0  days after defervescence, which we defined as con­
valescence. No patients died.
C ytokine measurements. On admission and during convales­
cence, blood was drawn for cytokine measurement. Venous 
blood samples were aseptically collected into sterile 4-mL tubes 
(Vacutainer; Becton Dickinson, Rutherford, NJ) containing  
EDTA. Unless stated otherwise, a total o f  3 tubes o f  blood was 
drawn from each patient [23]. To each tube, 250 ¿¿L o f  aprotinin 
(Trasylol 2500  kallikreine inactivating units [KIU]; Bayer, Le­
verkusen, Germany; final concentration 625 K IU /m L) was 
added through the stopper by a tuberculin needle and syringe. 
One tube was centrifuged directly (1250  g, 10 min), platelets 
from the supernatant plasma were removed by a second centrifu­
gation (15 ,000  g, 1 min), and plasma was collected and stored at 
—20°C  until assayed for cytokines. To one o f  the two remaining 
tubes, 50 fiL o f  LPS (Escherichia coli serotype 055:B 5; Sigma, 
St. Louis; final concentration 10 ¿ig/mL) was added to stimulate 
cytokine production. Unstimulated samples contained apro­
tinin only (no LPS). Both tubes were incubated at 37°C  for 24 h.
For 17 (random) patients, a fourth 4-mL tube o f  blood was 
obtained in the acute phase into which indomethacin was added 
(0.5 jug/m L final concentration). For 26 (random) patients, we 
obtained a total o f  six tubes o f  blood. From two o f  these, we 
removed the plasma, replacing it with a like amount o f  PBS.
T N F a  was determined by an RIA (detection level 100 pg/ 
mL), described in [25]. Normal T N F a  values for our laboratory 
(circulating concentrations and ex vivo production without LPS 
below the detection limit and ex vivo production after 24 h o f  
stimulation with LPS) are 3780  ±  950 pg/mL.
IL-1/3 was measured by RIA according to the method o f  Lisi 
et al. [26] but without chloroform extraction (detection level 
140 pg/mL). Normal values for our laboratory (circulating con­
centrations and ex vivo production without LPS below the de­
tection limit and ex vivo production after 24 h o f  stimulation 
with LPS) are 6930 ± 3 1 6 0  pg/mL.
IL-6 was measured by an ELISA as described (detection level,
20 pg/mL) [27]. Normal values for our laboratory (circulating 
concentrations and ex vivo production without LPS) were below  
the detection limit.
IL-8 was measured by ELISA quantikine (R & D Systems, 
Europe, Abingdon, UK). The detection limit was 45 pg/mL, 
and normal values were below the detection limit. We sought 
TNF/3 (lym photoxin) by ELISA quantikine (R & D Systems, 
Europe) but failed to detect any. IL-1RA was determined by an 
RIA according to the method o f  Poutsiaka et al. [28] (detection  
level 300 pg/mL). Normal values for our laboratory (circulating 
concentrations and ex vivo production without LPS below the 
detection limit, ex vivo production after 24 h stimulation with 
LPS) were 5757 ±  1060 pg/mL.
sTNF-R was measured by an enzyme-linked immunobinding  
assay (Hoffman-La Roche, Basel, Switzerland; detection level, 
80 and 300 pg/mL for p55 and p75, respectively). Normal val­
ues for circulating concentrations are 1.50 ng/mL (p55) and 
2.51 ng/m L (p75). All samples from the same patient were ana­
lyzed in the same run in duplicate to minimize analytical errors.
Statistics. When frequency distribution was parametric, we 
used paired and unpaired Student’s / test. When not parametric, 
W ilcoxon signed-rank test or Mann-W hitney U test was used. P  
<  .05 was considered significant.
Results
Circulating cytokines and inhibitors during acute and conva­
lescent phases o f typhoid fever. Concentrations of pyrogenic 
cytokines during the acute phase (IL-1/3, IL-6 , TNFa, lym­
photoxin) are shown in figure 1. IL-1/3 concentrations were 
below the detection limit in both acute and convalescent 
phases. IL-6 concentrations ranged from undetectable (<20 
pg/mL) to 600 pg/mL (median, 73). TNFa concentrations 
ranged from below the detection limit to 310 pg/mL (me-
1308 Keuter  et al J ID  1994:169 ( June )
1000
800
600
en
Q. 400
o
o
200
oLdb
œjomxuxxm
JJXXJ7) *8
8
IL-6 TNF IL-10 IL-8
Figure 1. Circulating concentrations o f pyrogenic cytokines in­
terleukin (IL)-l/?, tumor necrosis factor (TNF)-a, IL-6, and IL-8 in 
patients during acute phase o f  typhoid fever. Patients had been ill 
>  1 week. Horizontal continuous circles = detection limit; horizon­
tal bars = median values. In comparison with normal values, IL-6, 
IL-8, and TNFa are slightly elevated.
dian, 110) in the acute phase and to 3 0 0  pg/m L  (m edian , 
below  detection  lim it) during the con va lescen t phase. All 
lym photoxin  concentrations were below  detection  limits 
during acute and con va lescen t phases. IL-8 concentrations  
were detectable in the acute phase (m edian , 145; range, 4 7 -  
998  p g /m L ) but low er during the con va lescen t phase (m e ­
dian, 46; range, 4 6 - 1 8 0  pg/m L ).
Inhibitors such as IL -1R A  and sT N F -R  (p55  and p 75)
Circulating cytokines and inhibitors in complicated and un­
complicated disease. N o  differences were found in circulat­
ing cytokines or inhibitors betw een  the 16 patients with c o m ­
plicated and the 28 patients with uncom plicated  disease  
courses.
Ex vivo production o f cytokines and inhibitors during acute 
and convalescent phases. U nstim ulated  w h ole  b lood  cu l­
tures did not have detectable IL-1/3, T N F a , or IL-6 (n ot  
show n). After incubation with LPS for 24 h, the supernatants  
contained  detectable am ounts o f  these cytokines, w hich  
were significantly lower in the acute phase than in co n v a les­
cen ce  (IL-1/3: 2 5 4 7  ± 3 3 1 9  vs. 6 5 7 6  ±  6 2 7 5  pg/m L , P <  
.001; T N F a : 2 6 0 9  ±  2 4 4 3  vs. 6 3 3 8  ±  4 3 6 6  pg/m L , P  <  
.001; IL-6: 2 4 1 6  ±  1531 vs. 7 7 1 3  ±  3 8 0 9  pg/m L , P =  .01; 
figure 3).
In the acute phase, there was a correlation betw een  the 
LPS-stim ulated production o f  IL -1 and T N F a  ( r =  .6 6 4 ) ,  
IL-10 and IL-6 (r =  .5 3 1 ) ,  and T N F a  and IL-6 (r =  .434 ).
Such correlations were not found during con va lescen ce .
W hen  indom ethacin  was added to the stim ulated sam ples, 
the concentrations o f  T N F a  and IL-1 ¡3 in the acute phase  
were not different from those w ithout indom ethacin  (2 8 5 9  ±  
2 6 3 0  vs. 2 6 0 9  ±  2 4 4 3  and 2 7 8 2  ±  2821 vs. 2 5 4 7  ± 3 3 1 9  
pg/m L  for T N F a  and IL-1/?, with and w ithout in d om eth a­
cin, respectively). A lso , rem oval o f  plasm a and replacem ent  
with PBS did not change the stim ulated production o f  T N F a  
and IL-1 (3 in the acute phase (T N F a : 3 3 0 7  ±  3 9 2 0  pg/m L;  
IL-1/3: 2 2 4 4  ± 2 5 1 2  pg/m L ).
T h e IL -1R A  concentrations found in unstim ulated  cu l­
tures (n ot sh ow n ) were similar to those during the acute  
phase. H ow ever, the LPS-stim ulated production o f  IL-1 R A  
was high and reached significantly higher concentrations in
were significantly higher in the acute phase than during the the acute phase o f  the disease (5 6 0 8  ±  1832 p g /m L ) than
con va lescen t phase: IL -1R A , 2 3 0 4  ±  1427 p g /m L  versus during con va lescen ce  (3 9 7 7  ±  1974 pg/m L; P <  .05). sT N F -
4 6 9  ±  3 2 4  pg/m L; sT N F -R 5 5 , 4 9 7 3  ±  2 6 4 4  pg /m L  versus R, IL-8, and lym photoxin  were not generated in the cultures.
1671 ±  532  pg/m L; and sT N F -R 7 5 , 2 2 ,8 6 5  ±  15 ,143 pg / Ex vivo production o f cytokines and inhibitors during com-
mL versus 5971 ±  2 7 5 0  p g /m L  (figure 2). plicated and uncomplicated courses o f disease. In the acute
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Figure 2. Individual concentrations o f  circulating interleukin (IL)-1 receptor antagonist (ra) and tumor necrosis factor (sTNF-R) soluble 
receptors 55 and 75 in patients during acute and convalescent phases o f  typhoid fever. Inhibitors like IL-lra and sTNF-R (p55 and p75) 
were significantly higher in acute phase than during convalescent phase.
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Figure 3. Individual production capacity o f interleukin (IL)-l/3, tumor necrosis factor (TNF)-a, and IL-6 in acute and during convales­
cent phases o f  typhoid fever. After incubation with lipopolysaccharide for 24 h, supernatants contained detectable amounts o f  cytokines, 
which were significantly lower in acute phase than during convalescence.
phase, patients with com plicated  disease had significantly  
less IL-l/3 production after ex vivo stim ulation with LPS 
( 1341 ±  1373 vs. 6 5 6 3  ±  1342 pg/m L; P  <  .0 0 5 )  and a trend 
towards low er TNFa: production (1 6 5 0  ±  1407 vs. 3 0 6 4  ±  
2 7 7 0  pg/m L; P  =  .06). Such differences were not found for 
the production o f  IL-1 R A  or IL-6. D uring the con va lescen t  
phase, the ex v iv o -s t im u la ted  production o f  IL-1/? and  
TNFa: did not differ for com plicated  and un com p licated  
cases o f  disease.
Discussion
In this study we found several signs o f  cytokine activation  
during typhoid fever. T h e  concentrations o f  circulating inhib­
itors such as IL -1R A  and sT N F -R  were high in the acute  
phase o f  the disease. IL -1 R A  is know n not to be detectable in 
the circulation o f  normal subjects. N orm al values for sT N F -  
R are 1.50 n g /m L  (p 5 5 )  and 2.51 n g /m L  (p 7 5 )  [29, 30]. W e  
also found that the production capacity o f  pyrogenic cy to ­
kines in w h o le  b lood  is depressed in the acute phase o f  ty­
phoid fever but is restored during the con va lescen t phase. 
A lthough  the patients in our study usually had severe ty­
phoid  fever, we found that those with com plicated  disease  
courses had significantly low er proinflam m atory cytokine  
production capacity than did those with u n com p licated  dis­
ease.
A  low  production capacity o f  cytok ines has been  found in 
other serious cond ition s, such as severe postoperative in fec­
tion [31 ], sepsis [3 2 -3 4 ] ,  and attacks o f  familial M editerran­
ean fever [35, 36]. In these reports, all investigators used  
isolated peripheral b lood  m on on u clear  cells or tissue m acro­
phages. W e have previously found depressed cytokine pro­
duction capacity in the w h ole  b lood  culture system  during  
the acute phase o f  m en in gococca l disease and during Pneu­
m o cystis  carin ii in fection  (unpublished  data). From these  
studies and the work presented here, w e con clu d e  that the  
depressed cytokine production capacity is not a con seq u en ce  
o f  fewer w hite b lood cells during the acute phase o f  the in fec­
tion, since w e found no correlation betw een  leukocyte count  
and cytokine production (table 1).
M any investigators [31 - 3 6 ]  have interpreted the finding o f  
low  cytokine production capacity as exhaustion  o f  cytokine-  
producing cells, w hich cou ld  be a con seq u en ce  o f  exposure  
in vivo to stim uli such as en d otox in . Our finding that IL- 
1RA is produced in high concentrations argues against such  
a hypothesis and also rules out the possibility that the de­
creased production o f  proinflam m atory cytokines is due to 
an en h an ced  lysis o f  producing cells or to increased inactiva­
tion o f  LPS by lipids in the acute phase. A lthough  w e have  
been unable to dem onstrate that the proinflam m atory cy to ­
kines and IL -1 R A  are produced by the sam e kind o f  cells, w e  
hypothesize  that after the initial phase o f  in fection , cytok ine-  
producing cells switch from a balanced proinflam m atory to 
an antiinflam m atory repertoire. Our findings that patients in 
the acute phase o f  typhoid fever have high concentration  o f  
so lub le  sT N F -R s in their b lood  is in agreem ent with this 
notion .
Since our cultures used w h o le  b lood , w e investigated  
w hether som e co m m o n  circulating factor cou ld  be responsi­
ble for the correlated low production capacity o f  the cy to ­
kines IL-1/?, TNFa:, and IL-6 in the acute phase. C yclooxy-  
genase products, such as prostaglandin E2, w hich  inhibit
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production o f  IL-1 and T N F a  [37], were not responsible  
since addition o f  indom ethacin  to the w h ole  b lood cultures 
did not lead to significant changes in cytokine production. 
Likewise, removal o f  plasma and addition o f  saline before 
incubation did not overcom e the suppression in the acute  
phase o f  the disease.
It is possible that exposure in vivo to other inhibitory fac­
tors will explain the low  cytokine production capacity. 
Schindler et al. [38] dem onstrated that exposure o f  isolated  
m on on u clear  cells to IL-6 inhibits the production o f  IL-1 
and T N F a . In the present study, w e found no correlation  
betw een IL-6 concentrations in plasma and the m agnitude o f  
the production o f  IL-1 /? and T N F  (/* =  .041 and .035 , respec­
tively). Exposure to other cytokines such as, IL-4, IL -10. and  
transforming growth factor-/? could , however, play a role. 
V annier et al. [39] have provided ev idence  that exposure o f  
cells  to IL-4 suppresses the IL-1 production but up-regulates 
the synthesis o f  IL-1 RA.
W ith few exceptions, patients w'ith typhoid fever have a 
con tin u ou s fever. H ence, pyrogenic cytokines w ould  be ex ­
pected to be present in the circulation during the acute phase  
o f  the disease. In our series o f  febrile patients with typhoid  
fever, w'e cou ld  not detect appreciable concentrations o f  the 
pyrogenic cytokines IL-1/?, T N F a , and lym photoxin . The  
concentrations o f  IL-6, generally considered a relatively  
weak pyrogen [40], were low com pared to findings with  
other febrile cond itions [3, 41]. W e did detect elevated c o n ­
centrations o f  IL-8, but this cytokine is considered nonpyro-  
genic [42].
Thus, the question o f  which pyrogens are responsible for 
the con tin u ou s fever in typhoid fever remains unanswered.
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